交易中 10-06 10:13:46 美东时间
+0.245
+0.68%
Immunovant halts IMVT-1402 CLE trial after missing primary endpoints, driving IMVT and Roivant shares down in premarket trading.
09-23 21:03
Roivant Sciences shares are trading higher after the company announced its Phas...
09-08 19:46
HC Wainwright sees over $1 billion in sales potential for Argenx's Vyvgart in IMNM despite myositis trial changes.
06-26 01:57
US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe's Companies reported upbeat earnings.
05-21 00:16
Moderna stock rises after EU approval of flu-COVID combo vaccine mCOMBRIAX, backed by Phase 3 data showing strong immune response.
04-22 01:58
Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor concerns and clearing legal uncertainty.
03-04 21:14
The buyback program is inclusive of the $500M authorization that was approved in June 2025
03-04 05:19
Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
2025-12-12 02:39
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Roivant Sciences (NASDAQ:ROIV) will release its quarterly earnings report on Mo...
2025-11-07 22:01